Pharmaceutical Impurities

image(10)

Pharmaceutical Impurities

Pharmaceutical impurities and reference standards play a crucial role in ensuring the quality, safety, and efficacy of drug substances and formulations. Impurities are unintended substancesthat may arise during the synthesis, storage, or degradation of an API. Regulatory authorities mandate stringent impurity profiling and qualification to meet global compliance standards. Reference standards, on the other hand, serve as highly pure benchmarks for analytical testing, helping researchers and manufacturers confirm the identity, purity, and potency of pharmaceutical compounds. Their accurate characterization is essential for maintaining consistency and reliability in drug development and production.

At Zasya Life Sciences, we specialize in the custom synthesis of pharmaceutical impurities, offering tailored solutions to meet the unique needs of our clients. Our team of skilled scientists, backed by deep expertise in synthetic chemistry, provides high-quality impurities that are often challenging to source in the market. Whether it’s process-related, degradation, or API intermediates, we ensure the highest purity and analytical characterization to support regulatory submissions and R&D requirements.

Zasya extends its capabilities to peptide impurities, offering them exclusively through custom synthesis. Our expertise in complex molecular modifications allows us to design and synthesize peptide-related impurities that align with stringent research and quality control needs. With a commitment to innovation and excellence, we aim to be a trusted partner in impurity profiling, delivering superior-quality solutions with precision and reliability.

Eliglustat Impurity Fostemsavir Olsalazine Tegoprazan Tovorafenib ZLS
3-methyl-1H-1,2,4-triazole
3-methyl-1H-1,2,4-triazole

CAS No: 7170-01-6,

Mol.F: C3H5N3

Mol.Wt: 83.09

Inv. Status: In Stock

N-tosylformamide sodium salt
N-tosylformamide sodium salt

CAS No: 4917-56-0

Mol.F: C8H9NNaO3S

Mol.Wt: 222.22

Inv. Status: In Stock

phenyl(piperazin-1-yl)methanone hydrochloride
phenyl(piperazin-1-yl)methanone hydrochloride

CAS No: 56227-55-5

Mol.F: C11H15ClN2O

Mol.Wt: 226.70

Inv. Status: In Stock

2-(7-bromo-4-methoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetic acid
2-(7-bromo-4-methoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoacetic acid

CAS No: 954215-12-4

Mol.F: C10H7BrN2O4

Mol.Wt: 299.08

Inv. Status: In Stock

7-bromo-4-methoxy-1H-pyrrolo[2,3-c]pyridine
7-bromo-4-methoxy-1H-pyrrolo[2,3-c]pyridine

CAS No: 619331-35-0

Mol.F: C8H7BrN2O

Mol.Wt: 227.08

Inv. Status: In Stock

4-methoxy-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine
4-methoxy-1-(phenylsulfonyl)-1H-pyrrolo[2,3-c]pyridine

CAS No: 1421517-99-8

Mol.F: C14H12N2O3S

Mol.Wt: 288.32

Inv. Status: In Stock

1-(phenylsulfonyl)-6-tosyl-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4(5H)-one
1-(phenylsulfonyl)-6-tosyl-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4(5H)-one

CAS No: 1627136-94-0

Mol.F: C20H18N2O5S2

Mol.Wt: 430.50

Inv. Status: In Stock

1-(1-(phenylsulfonyl)-1H-pyrrol-3-yl)ethanone
1-(1-(phenylsulfonyl)-1H-pyrrol-3-yl)ethanone

CAS No: 81453-98-7

Mol.F: C12H11NO3S

Mol.Wt: 249.29

Inv. Status: In Stock

1-(phenylsulfonyl)-1H-pyrrole
1-(phenylsulfonyl)-1H-pyrrole

CAS No: 16851-82-4

Mol.F: C10H9NO2S

Mol.Wt: 207.25

Inv. Status: In Stock